Other common adverse events were nausea in ( 14 [ 23 % ] patients in MPa100Z group , 8 [ 13 % ] patients in MPa200Z group , 7 [ 12 % ] patients in HRZE group , and 8 [ 31 % ] patients in DRMPa200Z group ) and vomiting ( 7 [ 12 % ] patients in MPa100Z group , 7 [ 11 % ] patients in MPa200Z group , 7 [ 12 % ] patients in HRZE group , and 4 [ 15 % ] patients in DRMPa200Z group ) .